Did you know that Type 2 Diabetes can increase the risk of pancreatic as well as other cancers? Recently, Dr. Steve Edelman and the Taking Control Of Your Diabetes (@TCOYD) team highlighted the connection between #diabetes and #pancreaticcancer: tcoyd.org/2024/09/the-connec…

Avantect Ovarian Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services Learn more: clearnotehealth.com/press-re…

📢 ClearNote Health will be at the 14th World CB & CDx Boston Summit, Sept 3rd-6th. 📍Find us at #Booth35 and learn more about the advantages of the Virtuoso Epigenomics Platform for longitudinal analysis in your translational research. #drugdevelopment #therapyresponse

Join us at #TRICON as Samuel Levy, Chief Scientific Officer, shares how unlocking the full potential of #epigenomics will improve #cancer patient care through early detection: lnkd.in/ggXA78z4

We look forward to presenting @ASCO #GI23. Join @ClearNote Health poster session on Jan,20, 12:00 - 1:30 PM and 4:30-5:30 PM to learn about early detection of #PancreaticCancer using 5hmC-based #liquidbiopsy (abstract 672)

We look forward to providing an update on our progress with the Avantect Pancreatic Cancer Detection Test at #jpm23. Join Dave Mullarkey, CEO, today at 2:30 p.m. PST at the Westin St Francis, Mission Bay room #pancreaticcancer #precisionmedicine #earlydetection

Join Dave Mullarkey, CEO, at #JPM23 for a discussion on our ongoing clinical validation efforts and the commercialization roadmap for The Avantect™ Early #cancer Detection Portfolio. clearnotehealth.com/press-re…

#NEWS: Bluestar Genomics is now ClearNote Health. Our name has changed, but our goal remains the same – developing non-invasive tests to detect #cancer earlier than existing methods by harnessing the power of #epigenomics. clearnotehealth.com/press-re… #genomics #precisionmedicine

Today we announced the initiation of one of the largest #PancreaticCancer studies to date using epigenomic approach to enable #earlydetection. Learn more: bluestargenomics.com/press-r…

Join us tomorrow for a presentation by @Samuel Levy, Bluestar Genomics Chief Science Officer, at @The Lustgarten Foundation's webinar focused on innovation in early detection of #PancreaticCancer. Register now: lnkd.in/d5rUCKF8 #genomics #cancer #EarlyDetection